SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Revlon, Inc. (REV) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 16/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — REV
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-12.35
Book Value / Share$0.00
Revenue / Share$19.59
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$-0.11 |
$1.49B |
$-5.8M |
-0.4% |
| 2014 |
$0.78 |
$1.94B |
$40.9M |
2.1% |
| 2015 |
$1.07 |
$1.91B |
$56.1M |
2.9% |
| 2016 |
$-0.42 |
$2.33B |
$-21.9M |
-0.9% |
| 2017 |
$-3.48 |
$2.69B |
$-183.2M |
-6.8% |
| 2018 |
$-5.57 |
$2.56B |
$-294.2M |
-11.5% |
| 2019 |
$-2.97 |
$2.42B |
$-157.7M |
-6.5% |
| 2020 |
$-11.59 |
$1.9B |
$-619M |
-32.5% |
| 2021 |
$-3.83 |
$2.08B |
$-206.9M |
-10% |
| 2022 |
$-12.35 |
$1.08B |
$-677.8M |
-63% |
